| Authors | Tarek Hassanein, Karen D Sims, Michael Bennett, Norman Gitlin, Eric Lawitz, Tuan Nguyen, Lynn Webster, Zobair Younossi, Howard Schwartz, Paul J Thuluvath, Helen Zhou, Bhaskar Rege, Fiona McPhee, Nannan Zhou, Megan Wind-Rotolo, Ellen Chung, Amber Griffies, Dennis M Grasela, David F Gardiner |
| Journal | Journal of hepatology
(J Hepatol)
Vol. 62
Issue 5
Pg. 1204-6
(May 2015)
ISSN: 1600-0641 [Electronic] Netherlands |
| PMID | 25559328
(Publication Type: Clinical Trial, Phase II, Letter, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- 8-cyclohexyl-N-((dimethylamino)sulfonyl)-1,1a,2,12b-tetrahydro-11-methoxy-1a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)cycloprop(d)indolo(2,1-a)(2)benzazepine-5-carboxamide
- Antiviral Agents
- Benzazepines
- Carbamates
- Enzyme Inhibitors
- Imidazoles
- Indoles
- Isoquinolines
- Pyrrolidines
- Sulfonamides
- Valine
- daclatasvir
- asunaprevir
|
| Topics |
- Adult
- Antiviral Agents
(administration & dosage, adverse effects)
- Benzazepines
(administration & dosage, adverse effects)
- Carbamates
- Drug Monitoring
- Drug Resistance, Viral
- Enzyme Inhibitors
(administration & dosage, adverse effects)
- Female
- Hepacivirus
(drug effects, genetics)
- Hepatitis C, Chronic
(drug therapy, virology)
- Humans
- Imidazoles
(administration & dosage, adverse effects)
- Indoles
(administration & dosage, adverse effects)
- Isoquinolines
(administration & dosage, adverse effects)
- Male
- Middle Aged
- Pyrrolidines
- Sulfonamides
(administration & dosage, adverse effects)
- Treatment Outcome
- Valine
(analogs & derivatives)
|
